SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)
This Phase I project aims to develop a technology to simultaneously measure three biomarkders for early prostate cancer detection using an electronic radio frequency (RF) light-powered microtransponder. Antigens will be captured using antibodies coupled to the microtransponders and detected using biotinylated antibodies.
Small Business Information at Submission:
PHARMASEQ, INC. 11 DEER PARK DR, STE 104 MONMOUTH JUNCTION, NJ 08852
Number of Employees: